MS disease. Multiple sclerosis (of):NOS brain stem cord disseminated generalized
Conditions
Interventions
Intervention 1: The intervention group included people with MS who on the first day of the study and on the 50th day of the study "after swallowing a capsule containing 350 mg of royal jelly lyophiliz
Sponsors
Dezfoul University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: Age of patients should be 20-45 The sub type of M.S should be "Relapsing-Remitting MS" (RRMS). The diagnosis of "RRMS" is confirmed by a neurologist based on neurological examination and imaging. Patients should be treated with "Interferon" for at least 6 months.
Exclusion criteria
Exclusion criteria: Patients with anemia, Chronic Heart Disease, lung disease, Diabetic mellitus, Autoimmune diseases such as Rheumatoid Arthritis, SLE, ... Patients treated with corticosteroids or ACTH. Use of any supplements by patients. History of asthma and allergies in the patient. Occurrence of allergic symptoms during the study Occurrence of a "MS" attack during the study period. The patient' s refuse to continue study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The rate of change of oxidative stress state. Timepoint: Evaluation of "oxidative stress status" at the beginning of the study and on day 30 after the use of Royal Jelly. Method of measurement: The assay of Malondialdehyde , Superoxide dismutase, Catalase, Nitric oxide. | — |
Secondary
| Measure | Time frame |
|---|---|
| Expanded Disability Status Scale. Timepoint: Study of "Expanded Disability Status Scale" at the beginning of the study and on day 30 after the use of Royal Jelly. Method of measurement: Scoring from zero (best condition) to 10 (death due to MS) according to the neurologist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Susan Sabbagh
Dezfoul University of Medical Sciences
Outcome results
None listed